Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

First Patient Of NOTES Investigational Device Exemption (IDE) Study Successfully Treated With Ethicon Endo-Surgery Devices
Ethicon Endo-Surgery, Inc. announced the successful treatment of the first patient of its IDE feasibility trial. The case, which was performed at The Ohio State University Center for Minimally Invasive Surgery, marks the first natural orifice translumenal endoscopic surgery (NOTES) procedure involving the company"s investigational devices. NOTES is a surgical method in which external incisions are eliminated, potentially leading to reduced pain, a quicker recovery and a faster return to normal activities for the patient.

Blanchette Rockefeller Neurosciences Institute And Inverness Medical Innovations To Develop Commercial Test To Detect Early Alzheimer's Disease
The Blanchette Rockefeller Neurosciences Institute (BRNI) and Inverness Medical Innovations, Inc. (Inverness, NYSE: IMA) of Waltham, Massachusetts, a global leader in rapid diagnostics and health management, announced today that they will work together to further develop and commercialize a diagnostic test for Alzheimer"s disease first discovered by scientists at BRNI.
News of the day
Today's Selection Of Opinions And Editorials
Wrong Health Reform Will Hurt Economy Politico
Mental Health

Limbal Stem Cells - To Be Or Not To Be?

There has been a recent questioning of the role of the limbal stem cell in corneal maintenance and the recent Association for Research in Vision and Ophthalmology (ARVO) meeting in Fort Lauderdale May 3 -7, 2009 saw some fairly hot debate son this topic. Professor Colin Green, University of Auckland, New Zealand reviews an interesting series of sessions for The Society for Clinical Ophthalmology. The almost universally accepted "X,Y,Z" model for the natural turnover of corneal epithelial cells arose from the brief two page hypothesis of Thoft and Friend published in 1983 (Invest Ophthalmol Vis Sci. 1983;24:1442-3). Superficial cells are said to shed from the corneal surface by constant desquamation (Z component) and replaced from a population of stem cells which reside in the basal limbal region and continue to cycle slowly throughout life. Their daughter cells migrate centripetally (Y component) into the basal layer of the corneal epithelium and differentiate into upper layers of the cornea (X component) to become post-mitotic cells. The "X, Y, Z" hypothesis has been widely accepted and combined with the general belief that corneal epithelial stem cells reside in a highly specialised and protected limbal niche. Recently FranÃýois Majo and colleagues (Nature. 2008;456:250-4) suggested instead that oligopotent stem cells are distributed throughout the mammalian ocular surface and Chang et al. (Invest Ophthalmol Vis Sci. 2008;49:5279-86) have shown that the central human cornea expresses stem cell markers and is quite capable of healing after laser ablation in an ex vivo model. Presentations at the recent ARVO meeting (May 3 -7) were set to be controversial and both poster and workshops sessions saw lively debate. The full article can be accessed through the Society for Clinical Ophthalmology"s website, click here. The Society welcomes submissins and comments from eye care practitioners across all specialities. If you were at ARVO, we are particularly keen to hear from you. Society for Clinical Ophthalmology


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009